| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | - | - | - | - | - | - | - | - |
| 1 | - | - | - | - | - | 2.0 | 26.0 | - | - | - | 28.0 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 23 |
| 1 | 183 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | 193 |
| 1 | 223 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 28 |
| Number of output connections: | 110 |
| Coverage factor: | 1.0 |
| Columnar completeness: | 0.00 |
| Area completeness: | 0.00 |
| Cell size (columns): | 4 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| instance | NT | total connections | connections /#aMe10 (L) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | aMe5 (R) | ACh | 14 | 14.0 | 48.3% | 48.3% |
| 1 | aMe1 (R) | GABA | 6 | 6.0 | 20.7% | 69.0% |
| 2 | aMe4 (R) | ACh | 2 | 2.0 | 6.9% | 75.9% |
| 3 | MeVPaMe2 (L) | Glu | 2 | 2.0 | 6.9% | 82.8% |
| 4 | MeVPMe6 (L) | Glu | 2 | 2.0 | 6.9% | 89.7% |
| 5 | 5thsLNv_LNd6 (R) | ACh | 1 | 1.0 | 3.4% | 93.1% |
| 6 | aMe12 (R) | ACh | 1 | 1.0 | 3.4% | 96.6% |
| 7 | HBeyelet (R) | His | 1 | 1.0 | 3.4% | 100.0% |
| instance | NT | total connections | connections /#aMe10 (L) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | aMe4 (R) | ACh | 565 | 565.0 | 51.1% | 51.1% |
| 1 | MeVPaMe2 (R) | Glu | 91 | 91.0 | 8.2% | 59.3% |
| 2 | aMe10 (R) | ACh | 86 | 86.0 | 7.8% | 67.1% |
| 3 | aMe5 (R) | ACh | 83 | 83.0 | 7.5% | 74.6% |
| 4 | aMe1 (R) | GABA | 79 | 79.0 | 7.1% | 81.7% |
| 5 | aMe15 (R) | unclear | 54 | 54.0 | 4.9% | 86.6% |
| 6 | MeVPaMe2 (L) | Glu | 20 | 20.0 | 1.8% | 88.4% |
| 7 | aMe23 (R) | unclear | 14 | 14.0 | 1.3% | 89.7% |
| 8 | Cm30 (R) | GABA | 11 | 11.0 | 1.0% | 90.7% |
| 9 | MeVPMe12 (R) | ACh | 11 | 11.0 | 1.0% | 91.7% |
| 10 | aMe17b (R) | GABA | 10 | 10.0 | 0.9% | 92.6% |
| 11 | aMe20 (R) | unclear | 10 | 10.0 | 0.9% | 93.5% |
| 12 | aMe6b (R) | ACh | 10 | 10.0 | 0.9% | 94.4% |
| 13 | Cm24 (R) | Glu | 9 | 9.0 | 0.8% | 95.2% |
| 14 | PLP211 (R) | unclear | 7 | 7.0 | 0.6% | 95.8% |
| 15 | aMe25 (R) | unclear | 5 | 5.0 | 0.5% | 96.3% |
| 16 | Cm33 (R) | GABA | 5 | 5.0 | 0.5% | 96.7% |
| 17 | Lat2 (R) | unclear | 5 | 5.0 | 0.5% | 97.2% |
| 18 | MeVPMe11 (R) | Glu | 4 | 4.0 | 0.4% | 97.6% |
| 19 | Cm35 (R) | GABA | 3 | 3.0 | 0.3% | 97.8% |
| 20 | aMe24 (R) | unclear | 2 | 2.0 | 0.2% | 98.0% |
| 21 | aMe6a (R) | ACh | 2 | 2.0 | 0.2% | 98.2% |
| 22 | LoVP38 (R) | Glu | 2 | 2.0 | 0.2% | 98.4% |
| 23 | MeVP11 (R) | ACh | 2 | 2.0 | 0.2% | 98.6% |
| 24 | MeVPaMe1 (R) | ACh | 2 | 2.0 | 0.2% | 98.7% |
| 25 | MeVPMe12 (L) | ACh | 2 | 2.0 | 0.2% | 98.9% |
| 26 | SLP250 (R) | unclear | 2 | 2.0 | 0.2% | 99.1% |
| 27 | aMe22 (R) | Glu | 1 | 1.0 | 0.1% | 99.2% |
| 28 | CL083 (R) | unclear | 1 | 1.0 | 0.1% | 99.3% |
| 29 | CL125 (R) | unclear | 1 | 1.0 | 0.1% | 99.4% |
| 30 | Cm15 (R) | GABA | 1 | 1.0 | 0.1% | 99.5% |
| 31 | l-LNv (R) | unclear | 1 | 1.0 | 0.1% | 99.5% |
| 32 | MeVC20 (R) | Glu | 1 | 1.0 | 0.1% | 99.6% |
| 33 | MeVC23 (R) | Glu | 1 | 1.0 | 0.1% | 99.7% |
| 34 | MeVP6 (R) | Glu | 1 | 1.0 | 0.1% | 99.8% |
| 35 | SLP249 (R) | unclear | 1 | 1.0 | 0.1% | 99.9% |
| 36 | Tm30 (R) | GABA | 1 | 1.0 | 0.1% | 100.0% |